Literature DB >> 7806272

The Asp116-His116 substitution in a novel HLA-B27 subtype influences the acceptance of the peptide C-terminal anchor.

M T Fiorillo1, G Greco, R Sorrentino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7806272     DOI： 10.1007/bf00188430

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  8 in total

1.  HLA class I nucleotide sequences, 1992.

Authors:  J Zemmour; P Parham
Journal:  Hum Immunol       Date:  1992-08       Impact factor: 2.850

2.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

4.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  A monoclonal antibody that recognizes HLA-B27 in the context of peptides.

Authors:  J Wang; D T Yu; T Fukazawa; H Kellner; J Wen; X K Cheng; G Roth; K M Williams; R B Raybourne
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

6.  Analysis of HLA-B*2705 peptide motif, using T2 cells and monoclonal antibody ME1.

Authors:  J Wen; J Wang; J G Kuipers; F Huang; K M Williams; R B Raybourne; D T Yu
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T cell clone.

Authors:  P Del Porto; M D'Amato; M T Fiorillo; L Tuosto; E Piccolella; R Sorrentino
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

8.  The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides.

Authors:  D Fruci; G Greco; E Vigneti; N Tanigaki; R H Butler; R Tosi
Journal:  Hum Immunol       Date:  1994-09       Impact factor: 2.850
  8 in total
  3 in total

1.  Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27.

Authors:  Begoña Galocha; José A López de Castro
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

2.  Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes.

Authors:  Kathrin Winkler; Anja Winter; Christine Rueckert; Barbara Uchanska-Ziegler; Ulrike Alexiev
Journal:  Biophys J       Date:  2007-06-15       Impact factor: 4.033

Review 3.  HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

Authors:  J A Lopez De Castro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.